Modulation of T Cell Activation and Tolerance by DRAK2
Modulation of T Cell Activation and Tolerance by DRAK2
批准号:
7430248
负责人:
Craig Michael Walsh
金额:
$4.5万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-05 至 2009-02-28
关键词:
AddressAgonistApoptosisAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiological AssayCCL21 geneCD28 geneCalciumCell DeathCell LineCellsClonal ExpansionCollagen ArthritisDefectDevelopmentEctopic ExpressionEngineeringFamilyGene ActivationGenesHomeostasisImmune ToleranceLigationLymphocyteLymphoidLymphoid TissueLymphoproliferative DisordersMaintenanceMediator of activation proteinModelingMusMutagenesisNuclear TranslocationNumbersOrganPathway interactionsPeripheralPhosphorylationPhosphotransferasesPlayPredispositionPreventionProcessProliferatingPropertyProtein-Serine-Threonine KinasesRegulationResearch PersonnelRoleSignal PathwaySignal TransductionStagingSuperantigensT cell regulationT-Cell ActivationT-Cell Activation PathwayT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingThymus Glandcrosslinkdiaminopyrimidinein vivomembermutantnovelpreventprogramsresearch studyresponseretroviral-mediatedthymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Although immune tolerance is clearly important for the prevention of autoimmunity and the maintenance of lymphocyte
homeostasis, suprisingly little is known about the intracellular signaling pathways that are involved. To this end, we have
identified DRAK2, a serine/threonine kinase that is highly enriched in lymphoid tissues. As a member of the DAP family
of kinases, DRAK2 induces apoptosis upon ectopic expression in certain cell lines. In mice with an engineered deficiency
in DRAK2, a number of important defects in T lymphocyte development and activation are apparent. T cells derived from
these mice are hyperproliferative to suboptimal stimulation through the T cell receptor, indicating an unexpected role in T
cell quiescence for this kinase. In accord with this finding, DRAK2"'" mice have an increased proportion of activated T
cells in peripheral lymphoid organs. Furthermore, DRAK2-deficient T cells proliferate in the absence of costimulatory
signals normally required for T cell activation. We have found that whereas wildtype T cells require crosslinking of both
the T cell receptor (TCR) and CD28 for a rapid and sustained calcium response, DRAK2-deficient T cells require only
stimulation via the TCR. Paradoxically, clonal expansion following superantigen exposure is dramatically defective in
DRAK2-deficient T cells. This defective responsiveness to superantigen is due to enhanced activation-induced cell death
(AICD). We are curious about the mechanisms by which DRAK2 interferes with T cell activation and how its activity may
modulate immune tolerance. We will determine if known T cell activation pathways are defective in DRAK2"'" mice. We
will characterize the kinase biochemically to determine its mode of action. Finally, we will assess the consequences of its
absence when AICD is blocked. These results are aimed at providing a more thorough understanding of negative
regulation of T cell activation, and how such negative regulation contributes to immune tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperion multi-parameter high-dimensional imaging mass cytometry platform
-
批准号:10193821
-
项目类别:
-
资助金额:$59.99万
-
财政年份:2021
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:8093107
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2010
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:7917835
-
项目类别:
-
资助金额:$3.44万
-
财政年份:2009
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:7072289
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
GROWTH REGULATION OF ACTIVATED T CELLS BY FADD
-
批准号:7182391
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:6983696
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:7197336
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:7570029
-
项目类别:
-
资助金额:$26.96万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
Modulation of T Cell Activation and Tolerance by DRAK2
-
批准号:7379929
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2005
-
负责人:Craig Michael Walsh
-
依托单位:
Growth Regulation of Activated T Cells by FADD
-
批准号:6683606
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2002
-
负责人:Craig Michael Walsh
-
依托单位:
Growth Regulation of Activated T Cells by FADD
-
批准号:6982829
-
项目类别:
-
资助金额:$25.71万
-
财政年份:2002
-
负责人:Craig Michael Walsh
-
依托单位:
Growth Regulation of Activated T Cells by FADD
-
批准号:6572770
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2002
-
负责人:Craig Michael Walsh
-
依托单位:
Growth Regulation of Activated T Cells by FADD
-
批准号:6827361
-
项目类别:
-
资助金额:$26.26万
-
财政年份:2002
-
负责人:Craig Michael Walsh
-
依托单位:
Growth Regulation of Activated T Cells by FADD
-
批准号:7148698
-
项目类别:
-
资助金额:$24.93万
-
财政年份:2002
-
负责人:Craig Michael Walsh
-
依托单位:
DEATH RECEPTOR SIGNALING PATHWAYS IN T CELL DEVELOPMENT
-
批准号:6455741
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2001
-
负责人:Craig Michael Walsh
-
依托单位:
DEATH RECEPTOR SIGNALING PATHWAYS IN T CELL DEVELOPMENT
-
批准号:6070140
-
项目类别:
-
资助金额:$4.09万
-
财政年份:2000
-
负责人:Craig Michael Walsh
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: